Puma Biotech Strikes Deal to Develop and Market its Breast Cancer Drug in China - Los Angeles Business Journal
Puma Biotechnology
Puma – PHARMA
Former Puma Biotech Executive Gets U.S. Prison Term for Insider Trading
PUMA BIOTECHNOLOGY, INC. : Precios y cotizaciones Acción | PBYI | US74587V1070 | MarketScreener
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer
Puma – PHARMA
Resumen: Puma Biotechnology y Pierre Fabre modifican el acuerdo de licencia de NERLYNX® para incluir la Gran China | Business Wire
Puma Biotechnology
Puma – PHARMA
Puma Biotechnology Reports Results of PB272 (neratinib) in P-III NALA Trial for Patients with 2L+ HER2+ Metastatic Breast Cancer #ASCO2019
Medical Affairs eLearning - MSL Society
Resumen: Puma Biotechnology y Pierre Fabre firman acuerdo de licencia exclusiva para desarrollar y comercializar NERLYNX® (neratinib) en Europa | Business Wire
Puma Biotechnology
Does Puma's quick Nerlynx launch play into its buyout prospects? | Fierce Pharma
PharmaBg
El negocio bursátil de PUMA BIOTECHNOLOGY – Observatorio de biopolitica
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
Ex-Puma exec charged with insider trading, hit with criminal charges | Fierce Biotech
Compra Acciones de Puma Biotechnology Inc y Comprueba ($PBYI) su Precio de Mercado en eToro.
Puma Biotechnology
Puma Biotechnology: Still Bullish At These Prices (NASDAQ:PBYI) | Seeking Alpha
Buy Hering Pharma Muira Puma Mother Tincture Q 30ml | ShopHealthy.in
